rs886038201
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP5BP4
The NM_014804.3(KIAA0753):c.1546-3C>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,613,824 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_014804.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIAA0753 | ENST00000361413.8 | c.1546-3C>A | splice_region_variant, intron_variant | 1 | NM_014804.3 | ENSP00000355250.3 | ||||
KIAA0753 | ENST00000572370.5 | c.649-3C>A | splice_region_variant, intron_variant | 2 | ENSP00000460050.1 | |||||
KIAA0753 | ENST00000542826.6 | n.119-3C>A | splice_region_variant, intron_variant | 2 | ENSP00000444946.3 | |||||
KIAA0753 | ENST00000570790.5 | n.*692-3C>A | splice_region_variant, intron_variant | 2 | ENSP00000460816.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152146Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000802 AC: 2AN: 249354Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135280
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461678Hom.: 0 Cov.: 32 AF XY: 0.0000289 AC XY: 21AN XY: 727164
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152146Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74314
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 05, 2022 | Observed with a nonsense variant (p.(K631*)) in a newborn in published literature with oral-facial-digital syndrome, but it is not known whether the variants occurred on the same (in cis) or on different (in trans) chromosomes as the c.1546-3 C>A variant occurred apparently de novo (Chevrier et al., 2016); Although in silico analysis supports that this variant does not alter splicing, cDNA sequencing of an individual harboring this variant revealed heterozygous skipping of exon 8 leading to a frameshift and premature stop codon (Chevrier et al., 2016); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26643951) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 10, 2023 | This sequence change falls in intron 8 of the KIAA0753 gene. It does not directly change the encoded amino acid sequence of the KIAA0753 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has been observed in individual(s) with orofaciodigital syndrome (PMID: 26643951). ClinVar contains an entry for this variant (Variation ID: 254662). Studies have shown that this variant alters KIAA0753 gene expression (PMID: 26643951). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Joubert syndrome 38 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Mar 31, 2022 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Joubert syndrome 38 (MIM#619476). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0210 - Splice site variant proven to affect splicing of the transcript with a known effect on protein sequence. Sanger sequencing of cDNA obtained from an individual with orofaciodigital syndrome demonstrated exon 8 skipping. This results in a premature termination codon (p.(Asp439Glyfs*6), also annotated as p.(Asp439Glyfs*5) in the literature) which is predicted to undergo nonsense-mediated decay (NMD, PMID: 26643951). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (v2: 2 heterozygotes, 0 homozygotes). (SP) 0702 - Other premature termination variants comparable to the one identified in this case have strong previous evidence for pathogenicity. Multiple NMD-predicted variants have been reported in affected individuals and as likely pathogenic/pathogenic (PMID: 34523780, ClinVar). (SP) 0803 - This variant has limited previous evidence of pathogenicity in an unrelated individual. It has been reported de novo in an individual with orofaciodigital syndrome who is compound heterozygous with another nonsense variant, NM_014804.2:c.1891A>T; p.(Lys631*) (PMID: 26643951). (SP) 1002 - This variant has moderate functional evidence supporting abnormal protein function. The KIAA0753 protein was hardly detectable in the immortalised cells of an individual who also has a nonsense variant. The recruitment of its partner proteins onto the centrosomes was also reduced (PMID: 26643951). (SP) 1102 - Strong phenotype match for this individual. (SP) 1205 - This variant has been shown to be maternally inherited (by duo analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Orofaciodigital syndrome XV Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 22, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at